Literature DB >> 25099593

Fibrinolysis for intermediate-risk pulmonary embolism.

Eduardo Gonzalez, Hunter B Moore, Ernest E Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25099593      PMCID： PMC4375437          DOI： 10.1056/NEJMc1406283

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Detection of tPA-induced hyperfibrinolysis in whole blood by RapidTEG, KaolinTEG, and functional fibrinogenTEG in healthy individuals.

Authors:  Gustav Folmer Genét; Sisse Rye Ostrowski; Anne Marie Sørensen; Pär Ingemar Johansson
Journal:  Clin Appl Thromb Hemost       Date:  2012-01-31       Impact factor: 2.389

2.  Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy.

Authors:  Michael P Chapman; Ernest E Moore; Christopher R Ramos; Arsen Ghasabyan; Jeffrey N Harr; Theresa L Chin; John R Stringham; Angela Sauaia; Christopher C Silliman; Anirban Banerjee
Journal:  J Trauma Acute Care Surg       Date:  2013-12       Impact factor: 3.313

Review 3.  Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

Authors:  Koji Yamamoto; Kyosuke Takeshita; Tetsuhito Kojima; Junki Takamatsu; Hidehiko Saito
Journal:  Cardiovasc Res       Date:  2004-12-08       Impact factor: 10.787

4.  Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Michael P Chapman; Theresa L Chin; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2014-12       Impact factor: 3.313

5.  Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).

Authors:  P Angleton; W L Chandler; G Schmer
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.